Hygroton

Chlortalidone, the active ingredient in Hygroton, is a thiazide‑like diuretic presented as an oral dosage form for oral use. It is employed to manage elevated blood pressure and fluid retention in patients requiring antihypertensive or edematous therapy.

GNH USA supplies Hygroton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential antihypertensive agent.

Chlortalidone is used as a thiazide‑like diuretic to treat conditions related to excess fluid and high blood pressure.

Hypertension: lowers elevated blood pressure by promoting sodium and water excretion. Edema: reduces fluid accumulation in tissues by increasing urinary output of sodium and water. Congestive heart failure: assists in fluid management as an adjunct therapy.

Chlortalidone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination: frequent need to void. - Dizziness or light‑headedness: especially upon standing. - Headache: mild to moderate intensity. - Electrolyte disturbances (e.g., low potassium): due to enhanced sodium loss. - Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Hyponatremia or severe electrolyte imbalance: can lead to confusion or seizures. - Gout flare: elevated uric acid levels may precipitate attacks. - Pancreatitis: inflammation of the pancreas, presenting with abdominal pain. - Allergic reactions: rash, itching, or anaphylaxis. - Blood dyscrasias: such as agranulocytosis or thrombocytopenia.

When prescribing chlortalidone, clinicians should observe several safety considerations. - Monitor electrolytes: check serum potassium, sodium and magnesium regularly. - Assess renal function: evaluate creatinine clearance before and during therapy. - Use caution in gout: the drug can raise uric acid levels. - Adjust dose in the elderly: increased sensitivity to volume depletion. - Review concomitant medications: avoid drugs that may exacerbate electrolyte loss. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Chlortalidone interacts with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium toxicity. - NSAIDs: can reduce the diuretic effect and impair renal function. - Digoxin: enhanced serum digoxin levels due to electrolyte changes.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, ARBs): additive blood‑pressure lowering effect. - Antidiabetic agents: may potentiate hypoglycaemia. - Corticosteroids: increase risk of potassium loss. - Other diuretics: combined therapy can cause excessive fluid and electrolyte depletion. - Warfarin: may alter INR values.